2025年医药包装市场前景报告（英文版）

2025 Pharmaceutical Packaging Market ProspectsCPHI 2025 Pharmaceutical Packaging Market Prospects 2 Contents07 Contributors01 Key takeaways08 References02 IntroductionInnovations in packaging and drug deliveryBlockbuster drugs like GLP-1 agonists and biologics are driving interest in new pharmaceutical packaging solutions.Everchanging global and regional policies are proving to be a challenge to navigate for not just pharmaceutical packagers, but the industry as a whole.Addressing gaps in patient-centred care will be a growing priority for pharma packagers and drug delivery companies looking to remain relevant and competitive.Sustainability remains a top concern for pharmaceutical packagers, with focus on material lifecycle management and regulatory challenges and incentives.Delivering on sustainability initiatives Regional policies and shifting priorities for packaging Putting patients first with packaging03040506 Key takeawaysCPHI 2025 Pharmaceutical Packaging Market Prospects 401 Key takeawaysKey takeaways 1/2Pharmaceutical packaging innovation takes place early in the development processMore and more, the pharmaceutical industry is realising that to achieve goals like sustainability, patient-centricity, and unique drug packaging and delivery solutions, packaging considerations must come earlier in the development process.Regulators and legislation must enforce and harmonise pharmaceutical sustainabilityIn order to truly establish a sustainable industry, including pharmaceutical packaging, the industry will need harmonisation from regional and global regulators to incentivise and drive efforts towards sustainability.Biologics demanding new packaging solutions for disease indicationsThe rise of biologics and their specialised requirements regarding cold chain and specific delivery needs are bringing new opportunities to the pharmaceutical packaging sector.CPHI 2025 Pharmaceutical Packaging Market Prospects 5Drawing inspiration from other industries could drive pharma packaging innovationIndustries such as cosmetics and FMCG, where packaging innovations have already been implemented, could serve as guidelines for the pharmaceutical industry looking to up their sustainability game or meet specific drug demands.Pharma supply chain to remain increasingly complex, packaging includedThe pharmaceutical supply chain remains a complex web, especially with the BIOSECURE Act and tariffs affecting partnerships across the globe. Pharmaceutical packagers are not exempt from this, and the effects of these shifting attitudes on future of strategic collaborations remains to be seen.01 Key takeawaysKey takeaways 2/2 IntroductionCPHI 2025 Pharmaceutical Packaging Market Prospects 702 IntroductionIntroductionIn 2025 and the years to come, the pharmaceutical packaging sector is bracing for marked changes and opportunities for all. By the end of 2025, the packaging market for the broader healthcare industry is expected to reach US$159 billion, with predic